Latest Stories

Americans pay the most in the world for prescription medications. Are we getting our money's worth? Helen Palmer reports.

Funeral services for Jerry Falwell were held in Lynchburg, Va., today. Commentator Adrian Wooldridge says there was a side to Falwell that deserves some attention — that of religious entrepreneur.

As Treasury Secy. Henry Paulson met with his China counterpart, more reports of unsafe Chinese products surfaced today. Kai Ryssdal talks with China expert Ted Fishman about the U.S.-China relationship.

Procter & Gamble says it's doubling the strength of its detergents so it can reduce packaging and water use. But Pat Loeb reports that success will depend on whether consumers can change their behavior.

Beijing has sent its biggest-ever trade delegation to Washington for a summit on the trade deficit, debt, tarriffs and money policy. But don't get your hopes up for sweeping changes. Jeremy Hobson reports.

The social networking site recently booted 7,000 users and turned over contact data to authorities — but only after being subpoenaed. And a quick search reveals the purge didn't get everyone. Pat Loeb reports.

China's red-hot economy has become cause for political consternation here in the U.S., but it's also pumping up fears of a bubble bursting at home and leaders there are feeling some pressure. Scott Tong walks us through it.

EMI has agreed to a buyout offer from private equity firm Terra Firma. The timing of the news was surprising, says Billboard's Lars Brandle, but it seems the record company had some other bad news to bury.

Big sweepstakes prizes aren't just for the big kids anymore. One company is making it cost-effective for small and mid-sized businesses to offer prizes potential customers might give up their personal information to win. Sean Cole has the contest details.

GlaxoSmithKline stocks have continued their nosedive following release of a study that links the drugmaker's No. 2 seller to increased risk of heart attacks. But things could turn around. The FDA isn't taking action yet, Stephen Beard reports.